Exhibit 107
Calculation of Filing Fee Tables
FORM F-1
(Form Type)
OKYO PHARMA LIMITED
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | | Title of each Class of Securities to be Registered | | Fee Calculation Rule | | Amount
Registered (1) | | | Proposed
Maximum
Offering
Price Per
Share(2) | | | Maximum
Aggregate
Offering
Price | | | Fee Rate | | | Amount of
Registration
Fee(3) | |
| Equity | | Ordinary Shares, no par value(4) | | 457(c) | | | 10,153,740 | | | $ | 0.026 | | | $ | 263,997 | | | | .0001102 | | | $ | 29 | |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Registration Fee Previously Paid | | | | | | | | | | | | | | | | | | | | $ | 29 | |
| | | Registration Fee Paid Herewith | | | | | | | | | | | | | | | | | | | | $ | - | |
| (1) | Pursuant to Rule 416 under the Securities Act of 1933, as amended, OKYO Pharma Ltd. is also registering an indeterminate number of additional Ordinary Shares that may become issuable to prevent dilution from any stock dividend, stock split, recapitalization or other similar transactions that could affect the securities to be offered by the Registered Holders named in this Registration Statement, and the Ordinary Shares set forth in this table shall be adjusted to include such shares, as applicable). |
| | |
| (2) | Based on the average of the high and low prices of the ordinary shares on the Main Market of the London Stock Exchange on May 16, 2023 which was £0.0205 per share equivalent to $0.026 per ordinary share based on an exchange rate of £1.00 to $1.265. |
